The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Open accessAbstract
In this consensus document we summarize the current knowledge on major asthma, rhinitis, and atopic dermatitis endotypes under the auspices of the PRACTALL collaboration platform. PRACTALL is an initiative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology aiming to harmonize the European and American approaches to best allergy practice and science. Precision medicine is of broad relevance for the management of asthma, rhinitis, and atopic dermatitis in the context of a better selection of treatment responders, risk prediction, and design of disease-modifying strategies. Progress has been made in profiling the type 2 immune response-driven asthma. The endotype driven approach for non-type 2 immune response asthma, rhinitis, and atopic dermatitis is lagging behind. Validation and qualification of biomarkers are needed to facilitate their translation into pathway-specific diagnostic tests. Wide consensus between academia, governmental regulators, and industry for further development and application of precision medicine in management of allergic diseases is of utmost importance. Improved knowledge of disease pathogenesis together with defining validated and qualified biomarkers are key approaches to precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationWilliams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,598
Asthma phenotypes: the evolution from clinical to molecular approaches
Wenzel, S. E. (2012) · Nature Medicine · doi:10.1038/nm.2678 · Cited by 2,412
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,814
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
Self-citationT-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Type 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationDupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421
Self-citationMepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Naclerio, R. M. (2003) · Cited by 985
Exploring the Effects of Omalizumab in Allergic Asthma: An Analysis of Biomarkers in the EXTRA Study
Hanania, N. A., Wenzel, S., Rosén, K., Hsieh, H.-J., Mosesova, S., Choy, D. F., Lal, P., Arron, J. R., Harris, J. M., & Busse, W. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1414oc · Cited by 901
Greiner, A. N., Hellings, P. W., Rotiroti, G., & Scadding, G. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60130-x · Cited by 895
Self-citationGreen, R. H. (2002) · Thorax · doi:10.1136/thorax.57.10.875 · Cited by 848
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847
Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Akdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01153.x · Cited by 733
Self-citationEmollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
Defective epithelial barrier function in asthma
Xiao, C., Puddicombe, S. M., Field, S., Haywood, J., Broughton-Head, V., Puxeddu, I., Haitchi, H. M., Vernon-Wilson, E., Sammut, D., Bedke, N., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.038 · Cited by 637
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Application of moisturizer to neonates prevents development of atopic dermatitis
Horimukai, K., Morita, K., Narita, M., Kondo, M., Kitazawa, H., Nozaki, M., Shigematsu, Y., Yoshida, K., Niizeki, H., Motomura, K.-I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.060 · Cited by 607
Bullens, D. M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P. W., Dupont, L. J., & Ceuppens, J. L. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-135 · Cited by 587
Self-citationInternational consensus on allergy immunotherapy
Jutel, M., Agache, I., Bonini, S., Burks, A. W., Calderon, M., Canonica, W., Cox, L., Demoly, P., Frew, A. J., O'Hehir, R., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.047 · Cited by 545
Self-citationAkdis, C. A., Bachert, C., Cingi, C., Dykewicz, M. S., Hellings, P. W., Naclerio, R. M., Schleimer, R. P., & Ledford, D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.036 · Cited by 538
Self-citationChronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
Pène, J., Chevalier, S., Preisser, L., Vénéreau, E., Guilleux, M.-H., Ghannam, S., Molès, J.-P., Danger, Y., Ravon, E., Lesaux, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7423 · Cited by 527
Epithelium dysfunction in asthma
Holgate, S. T. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.025 · Cited by 489
Soyka, M. B., Wawrzyniak, P., Eiwegger, T., Holzmann, D., Treis, A., Wanke, K., Kast, J. I., & Akdis, C. A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.052 · Cited by 486
Rajan, J. P., Wineinger, N. E., Stevenson, D. D., & White, A. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.020 · Cited by 426
High IFN-γ and low SLPI mark severe asthma in mice and humans
Raundhal, M., Morse, C., Khare, A., Oriss, T. B., Milosevic, J., Trudeau, J., Huff, R., Pilewski, J., Holguin, F., Kolls, J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80911 · Cited by 393
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Piper, E., Brightling, C., Niven, R., Oh, C., Faggioni, R., Poon, K., She, D., Kell, C., May, R. D., Geba, G. P., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00223411 · Cited by 373
Brightling, C. E., Chanez, P., Leigh, R., O'Byrne, P. M., Korn, S., She, D., May, R. D., Streicher, K., Ranade, K., & Piper, E. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00197-6 · Cited by 369
The Effects of Airway Microbiome on Corticosteroid Responsiveness in Asthma
Goleva, E., Jackson, L. P., Harris, J. K., Robertson, C. E., Sutherland, E. R., Hall, C. F., Good, J. T., Gelfand, E. W., Martin, R. J., & Leung, D. Y. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0775oc · Cited by 363
Fajt, M. L., & Wenzel, S. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1871 · Cited by 353
Untangling asthma phenotypes and endotypes
Agache, I., Akdis, C., Jutel, M., & Virchow, J. C. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02832.x · Cited by 345
Self-citationMeasures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma
Peters, M. C., Mekonnen, Z. K., Yuan, S., Bhakta, N. R., Woodruff, P. G., & Fahy, J. V. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.036 · Cited by 342
Steelant, B., Farré, R., Wawrzyniak, P., Belmans, J., Dekimpe, E., Vanheel, H., Van Gerven, L., Kortekaas Krohn, I., Bullens, D. M. A., Ceuppens, J. L., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.050 · Cited by 336
Self-citationIrvin, C., Zafar, I., Good, J., Rollins, D., Christianson, C., Gorska, M. M., Martin, R. J., & Alam, R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.038 · Cited by 317
Bentley, A. M., Jacobson, M. R., Cumberworth, V., Barkans, J. R., Moqbel, R., Schwartz, L. B., Irani, A.-M. A., Kay, A. B., & Durham, S. R. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90444-7 · Cited by 274
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Saha, S. K., Berry, M. A., Parker, D., Siddiqui, S., Morgan, A., May, R., Monk, P., Bradding, P., Wardlaw, A. J., Pavord, I. D., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.005 · Cited by 255
Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma
Dougherty, R. H., Sidhu, S. S., Raman, K., Solon, M., Solberg, O. D., Caughey, G. H., Woodruff, P. G., & Fahy, J. V. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.003 · Cited by 254
Jutel, M., Agache, I., Bonini, S., Burks, A. W., Calderon, M., Canonica, W., Cox, L., Demoly, P., Frew, A. J., O'Hehir, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1300 · Cited by 244
Self-citationUncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?
Hellings, P. W., Fokkens, W. J., Akdis, C., Bachert, C., Cingi, C., Dietz de Loos, D., Gevaert, P., Hox, V., Kalogjera, L., Lund, V., et al. (2013) · Allergy · doi:10.1111/all.12040 · Cited by 225
Self-citationCzarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., Khattri, S., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.020 · Cited by 221
Brightling, C. E., Symon, F. A., Birring, S. S., Bradding, P., Pavord, I. D., & Wardlaw, A. J. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129698 · Cited by 217
Cho, S.-H., Stanciu, L. A., Holgate, S. T., & Johnston, S. L. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1416oc · Cited by 216
Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes
Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J., Fibbens, N. L., Powell, H., Cowan, D. C., Taylor, D. R., Cowan, J. O., & Gibson, P. G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1091 · Cited by 211
Czarnowicki, T., Esaki, H., Gonzalez, J., Malajian, D., Shemer, A., Noda, S., Talasila, S., Berry, A., Gray, J., Becker, L., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.049 · Cited by 210
Wagner, J. A., Williams, S. A., & Webster, C. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100017 · Cited by 201
Truyen, E. (2006) · Thorax · doi:10.1136/thx.2005.052399 · Cited by 196
Nemoto, O., Furue, M., Nakagawa, H., Shiramoto, M., Hanada, R., Matsuki, S., Imayama, S., Kato, M., Hasebe, I., Taira, K., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14207 · Cited by 193
Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine
Bieber, T. (2012) · Allergy · doi:10.1111/all.12049 · Cited by 190
Self-citationHaldar, P., Brightling, C. E., Singapuri, A., Hargadon, B., Gupta, S., Monteiro, W., Bradding, P., Green, R. H., Wardlaw, A. J., Ortega, H., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.026 · Cited by 185
Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report
Papadopoulos, N. G., Bernstein, J. A., Demoly, P., Dykewicz, M., Fokkens, W., Hellings, P. W., Peters, A. T., Rondon, C., Togias, A., & Cox, L. S. (2015) · Allergy · doi:10.1111/all.12573 · Cited by 182
Self-citationChambers, E. S., Nanzer, A. M., Pfeffer, P. E., Richards, D. F., Timms, P. M., Martineau, A. R., Griffiths, C. J., Corrigan, C. J., & Hawrylowicz, C. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.026 · Cited by 179
Holguin, F., Comhair, S. A. A., Hazen, S. L., Powers, R. W., Khatri, S. S., Bleecker, E. R., Busse, W. W., Calhoun, W. J., Castro, M., Fitzpatrick, A. M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1270oc · Cited by 165
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma
Raedler, D., Ballenberger, N., Klucker, E., Böck, A., Otto, R., da Costa, O. P., Holst, O., Illig, T., Buch, T., von Mutius, E., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.046 · Cited by 159
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis
Berry, M. A., Parker, D., Neale, N., Woodman, L. B., Morgan, A. J., Monk, P., Bradding, P. H., Wardlaw, A. J., Pavord, I. D., & Brightling, C. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.032 · Cited by 155
Biomarker-based asthma phenotypes of corticosteroid response
Cowan, D. C., Taylor, D. R., Peterson, L. E., Cowan, J. O., Palmay, R. D., Williamson, A., Hammel, J., ERZURUM, S. C., Hazen, S. L., & COMHAIR, S. A. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.026 · Cited by 152
Yoshida, K., Kubo, A., Fujita, H., Yokouchi, M., Ishii, K., Kawasaki, H., Nomura, T., Shimizu, H., Kouyama, K., Ebihara, T., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.001 · Cited by 145
Overview of Biomarkers and Surrogate Endpoints in Drug Development
Wagner, J. A. (2002) · Disease Markers · doi:10.1155/2002/929274 · Cited by 135
Leptin is an eosinophil survival factor
Conus, S., Bruno, A., & Simon, H. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.003 · Cited by 134
Self-citationAtopic dermatitis: a candidate for disease‐modifying strategy
Bieber, T., Cork, M., & Reitamo, S. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02845.x · Cited by 131
Self-citationGerven, L. V., Alpizar, Y. A., Wouters, M. M., Hox, V., Hauben, E. I., Jorissen, M., Boeckxstaens, G. E., Talavera, K., & Hellings, P. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.026 · Cited by 129
Self-citationHeightened response of eosinophilic asthmatic patients to the CRTH 2 antagonist OC 000459
Pettipher, R., Hunter, M., Perkins, C. M., Collins, L. P., Lewis, T., Baillet, M., Steiner, J. A., Bell, J. I., & Payton, M. A. (2014) · Allergy · doi:10.1111/all.12451 · Cited by 129
Impaired macrophage phagocytosis in non‐eosinophilic asthma
Simpson, J., Gibson, P. G., Yang, I. A., Upham, J., James, A. L., Reynolds, P. N., & Hodge, S. (2013) · Clinical and Experimental Allergy · doi:10.1111/j.1365-2222.2012.04075.x · Cited by 127
Han, N., Oh, H., Nam, S., Moon, P., Do‐Won, K. I. M., Kim, H.-M., & Jeong, H. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.198 · Cited by 121
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
Boyman, O., Kaegi, C., Akdiş, M., Bavbek, S., Bossios, A., Chatzipetrou, A., Eiwegger, T., Firinu, D., Harr, T., Knol, E. F., et al. (2015) · Allergy · doi:10.1111/all.12616 · Cited by 118
Self-citationPredicting steroid responsiveness in patients with asthma using exhaled breath profiling
van der Schee, M. P., Palmay, R. D., Cowan, J. O., & Taylor, D. R. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12147 · Cited by 112
Strategic paths for biomarker qualification
Goodsaid, F. M., Frueh, F. W., & Mattes, W. B. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.023 · Cited by 104
Interleukin-17 cytokine signalling in patients with asthma
Lindén, A., & Dahlén, B. (2014) · European Respiratory Journal · doi:10.1183/09031936.00002314 · Cited by 103
Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease
Steinke, J. W., Liu, L., Huyett, P. A., Negri, J. A., Payne, S. C., & Borish, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.008 · Cited by 95
Occupational upper airway disease: how work affects the nose
Hox, V., Steelant, B., Fokkens, W. J., Nemery, B., & Hellings, P. W. (2014) · Allergy · doi:10.1111/all.12347 · Cited by 88
Self-citationThe Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
Agache, I., Sugita, K., Morita, H., Akdis, M., & Akdis, C. A. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0529-x · Cited by 86
Self-citationGuidance for Industry: Pharmacogenomic Data Submissions
(2004) · Biotechnology Law Report · doi:10.1089/073003104322838303 · Cited by 83
Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response
Chang, X., Myers, J. M. B., Ji, H., Metz, K. A., Martin, L. J., Lindsey, M., He, H., Powers, R., Ulm, A., Ruff, B. P., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.045 · Cited by 79
Seys, S., Grabowski, M., Adriaensen, W. J., Decraene, A., Dilissen, E., Vanoirbeek, J., Dupont, L., Ceuppens, J. L., & Bullens, D. M. A. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12125 · Cited by 77
Self-citationFrom phenotypes to endotypes to asthma treatment
Agache, I. O. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32836093dd · Cited by 62
Self-citationNovel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
Radonjic‐Hoesli, S., Valent, P., Klion, A. D., Wechsler, M. E., & Simon, H. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124407 · Cited by 54
Self-citationImmunomodulatory effects of IL ‐23 and IL ‐17 in a mouse model of allergic rhinitis
Wang, M., Zhang, W., Shang, J., Yang, J., Zhang, L., & Bachert, C. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12123 · Cited by 52
Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
Li, L., Leung, D. Y. M., & Goleva, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141909 · Cited by 35
Dupilumab in Persistent Asthma
Wenzel, S. E., Wang, L., & Pirozzi, G. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1309809 · Cited by 35
Staudacher, A. G., Hinz, T., Novak, N., von Bubnoff, D., & Bieber, T. R. M. (2015) · Allergy · doi:10.1111/all.12699 · Cited by 32
Self-citationMeasuring the corticosteroid responsiveness endophenotype in asthmatic patients
Clemmer, G. L., Wu, A. C., ROSNER, B. A., McGeachie, M. J., Litonjua, A. A., Tantisira, K. G., & Weiss, S. T. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.029 · Cited by 24
Proinflammatory mediators in nasal lavage of subjects with occupational rhinitis
Castaño, R., Maghni, K., Castellanos, L., Trudeau, C., Malo, J., & Gautrin, D. (2010) · Otolaryngology · doi:10.1016/j.otohns.2010.04.272 · Cited by 18
Cited by
Bousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Walter Canonica, G., Melén, E., Palomares, O., Scadding, G. K., Togias, A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00227-0 · Cited by 942
The gut microbiome as a major regulator of the gut-skin axis
Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01459 · Cited by 707
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Self-citationAtopic dermatitis endotypes and implications for targeted therapeutics
Czarnowicki, T., He, H., Krueger, J. G., & Guttman-Yassky, E. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.032 · Cited by 631
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Werfel, T., Allam, J.-P., Biedermann, T., Eyerich, K., Gilles, S., Guttman-Yassky, E., Hoetzenecker, W., Knol, E., Simon, H.-U., Wollenberg, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.010 · Cited by 594
Self-citation
Metadata
- Authors
- Muraro, A., Lemanske, R. F., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., Simon, H.-U., Seys, S. F., & Agache, I.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 137
- Issue
- 5
- Pages
- 1347-1358
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2346391788
- Cited by
- 284
- References
- 93
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.